Effective Date 07/06/2021
| 3004160 |
2,3 Dinor-11Beta-Prostaglandin F2 Alpha, Random Urine |
Effective Date 06/29/2021
| 3003824 |
Brachyury by Immunohistochemistry |
Effective Date 06/22/2021
| 3003917 |
Distal Arthrogryposis Panel, Sequencing |
Effective Date 06/07/2021
| 3003913 |
Orthopedic Metals Panel (Chromium, Cobalt, Titanium) |
Effective Date 06/01/2021
| 3003648 |
COVID-19 IgG (Spike), Semi-Quantitative by CIA |
| 3002682 |
Heterotaxy & Situs Inversus Panel, Sequencing |
| 3001621 |
Primary Ciliary Dyskinesia Panel, Sequencing |
Effective Date 05/25/2021
| 3003729 |
Melan A by Immunohistochemistry (Red Detection) |
| 3003741 |
Melanoma Antibody, HMB45 by Immunohistochemistry (Red Detection) |
| 3003733 |
S-100 Protein by Immunohistochemistry (Red Detection) |
| 3003737 |
SOX-10 by Immunohistochemistry (Red Detection) |
Effective Date 05/24/2021
| 3003923 |
Allergen, Food, Alpha-Gal (galactose-alpha-1,3-galatose) IgE |
| 3003924 |
Allergen, Food, Alpha-Gal (galactose-alpha-1,3-galatose) Panel |
Effective Date 05/21/2021
| 3003830 |
Electron Microscopy Technical Only Request |
Effective Date 05/17/2021
| 3002582 |
Bacterial Vaginosis by TMA |
| 3002583 |
Candida glabrata, Candida species, and Trichomonas vaginalis by TMA |
| 3003756 |
Copper, Red Blood Cells |
| 3001581 |
Dilated Cardiomyopathy Panel, Sequencing |
| 3003760 |
Human Immunodeficiency Virus 1 (HIV-1) by Qualitative NAAT |
| 3001579 |
Hypertrophic Cardiomyopathy Panel, Sequencing |
| 3003751 |
JAK2 (V617F) Mutation by ddPCR, Quantitative |
| 3001593 |
MODY and Neonatal Diabetes Panel, Sequencing |
| 3001607 |
Osteogenesis Imperfecta and Low Bone Density Panel, Sequencing |
| 3003723 |
Propoxyphene and Metabolite, Serum or Plasma |
| 3003726 |
Propoxyphene and Metabolite, Urine |
| 3002581 |
Vaginitis Panel by TMA |
| 3003676 |
Vedolizumab Quantitation with Antibodies, Serum |
| 3003758 |
Zinc, Red Blood Cells |
Effective Date 03/29/2021
| 3001603 |
Long QT Panel, Sequencing and Deletion/Duplication |
Effective Date 03/22/2021
| 3003818 |
Cytochrome b5 Reductase Enzyme Activity |
Effective Date 03/09/2021
| 3002110 |
Familial Hypercholesterolemia Panel, Sequencing |
| 3001613 |
Stickler Syndrome Panel, Sequencing |
Effective Date 03/02/2021
| 3003704 |
CD71 by Immunohistochemistry |
| 3003816 |
Intact Fibroblast Growth Factor 23 (FGF23), Serum |
Effective Date 03/01/2021
| 3003606 |
Differential, Manual |
Effective Date 02/22/2021
| 3002528 |
Bacterial Strain Typing by Next Generation Sequencing |
| 3003279 |
Gastrointestinal Pathogens Panel by PCR |
Effective Date 02/16/2021
| 3002714 |
Acute Myeloid Leukemia Mutation Panel by Next Generation Sequencing |
| 2011966 |
Allergens, Food, Common Adult Food Profile 13 IgE |
| 2011967 |
Allergens, Pediatric, Common Profile IgE |
| 3003259 |
Cytokine Panel 13, CSF |
| 3003144 |
Deletion/Duplication Analysis by MLPA |
| 3002989 |
Hepatitis Panel, Acute with Reflex to HBsAg Confirmation and Reflex to HCV by Quantitative NAAT |
| 3001842 |
Hereditary Myeloid Neoplasms Panel, Sequencing |
| 3003486 |
Immunoglobulin D, Serum |
| 3003485 |
Immunoglobulin G, CSF |
| 3003261 |
Interleukin 2 Receptor, Soluble, CSF |
| 3003260 |
Interleukin 6, CSF |
| 3003506 |
Kappa/Lambda Light Chain Panel by in situ Hybridization on Paraffin |
| 3003525 |
Kappa/Lambda Light Chain Panel by In Situ Hybridization Stain Only |
| 3003311 |
Kratom (Mitragynine) - Screen with Reflex to Confirmation/Quantitation, Urine |
| 3003504 |
Squamous Cell Carcinoma, Serum |
Chat
